Regeneron Pharmaceuticals (REGN)

Depreciation & Amortization

$528.60M

TTM · Period ending: · USD

REGN logo

REGN Depreciation & Amortization

Latest reported$528.60M
REGN TTM Depreciation & Amortization ($2.00M → $528.60M)
High-resolution chart · PNG

REGN depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
528,600,000
540,000,000
543,700,000
525,100,000
510,100,000
495,700,000
482,900,000
469,500,000
453,200,000
435,600,000
421,000,000
408,100,000
395,300,000
366,600,000
341,400,000
315,800,000
296,400,000
293,100,000
286,200,000
273,400,000
259,500,000
247,200,000
235,900,000
228,500,000
222,100,000
215,400,000
210,300,000
198,759,000
181,300,000
162,842,000
148,200,000
139,948,000
142,226,000
143,710,000
145,467,000
139,860,000
129,980,000
119,883,000
104,745,000
98,755,000
91,590,000
81,859,000
74,909,000
66,134,000
59,465,000
57,183,000
52,686,000
49,843,000
46,641,000
43,327,000
41,204,000
39,690,000
38,216,000
37,931,000
36,940,000
35,088,000
34,035,000
32,520,000
31,082,000
29,242,000
25,860,000
22,482,000
19,687,000
18,536,000
17,232,000
15,706,000
14,247,000
11,938,000
11,122,000
11,065,000
11,287,000
11,560,000
11,645,000
11,578,000
11,487,000
11,984,000
12,833,000
13,649,000
14,592,000
15,076,000
15,303,000
15,444,000
15,504,000
15,540,000
15,481,000
15,447,000
15,362,000
15,760,000
15,540,000
14,422,000
12,937,000
10,672,000
9,185,000
8,734,000
8,454,000
8,215,000
7,565,000
6,756,000
6,077,000
5,563,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.